Accumulating evidence suggests that changes in the metabolic signature of microglia underlie their response to inflammation. We sought to increase our knowledge of how pro-inflammatory stimuli induce metabolic changes. Primary microglia exposed to lipopolysaccharide (LPS)-expressed excessive fission leading to more fragmented mitochondria than tubular mitochondria.
phological changes are observed in response to alterations in oxidative metabolism (Hackenbrock, 1966) , little is known of its role in microglia activation.
Microglia generate energy via both oxidative phosphorylation
(OXPHOS) and glycolysis (Orihuela, McPherson, & Harry, 2016) .
OXPHOS occurs within the mitochondria and is more efficient for ATP synthesis in comparison to glycolysis. However, the preferential use of glycolysis over OXPHOS for ATP production enables activated microglia to produce ATP at a faster rate (Schuster, Boley, Moller, Stark, & Kaleta, 2015) . Enhanced glycolysis supplies biosynthetic intermediates for cell growth and rapid production intermediates for cytokine production such as reactive oxygen species (ROS) thereby enabling effector functions (Chang et al., 2013; Everts et al., 2014) . In macrophages or dendritic cells (DCs), pro-inflammatory stimuli cause them to undergo a metabolic switch from OXPHOS to glycolysis, a phenomenon similar to the Warburg effect (Kelly & O'Neill, 2015) .
Microglia share many functions and characteristics with macrophages (Butovsky & Weiner, 2018) , but they are from a distinct nonhematopoietic lineage, and whether a similar switch from OXPHOS to glycolysis has not been explored in microglia.
We have previously found that both Toll-like receptor (TLR)-induced inflammation and mitochondrial dysfunction are involved in the development of neonatal brain injury (Hagberg, Mallard, Rousset, & Thornton, 2014; Mottahedin et al., 2017) . We have also found that mitochondrial ROS production and inflammation are increased after neonatal brain injury associated with altered Krebs cycle and succinate accumulation in the mitochondria (Koning et al., 2017) . Activation of microglia results in an altered Krebs cycle, as a result of metabolic switch promoting inflammatory gene expression (Gimeno-Bayon, Lopez-Lopez, Rodriguez, & Mahy, 2014; Leaw et al., 2017; Orihuela et al., 2016) . Katoh et al. found that mitochondrial fission via the activation of dynamin-related protein 1 (DRP1) (by TLR4 stimulation) increases mitochondrial fission but they did not look in to metabolism or cytokine production in microglia (Katoh et al., 2017) .
Here, we add data on how TLR4 activation affects mitochondrial morphology, energy metabolism, ROS, and cytokine production in microglia. This knowledge is important given the many roles of microglia in mediating host-defenses and how these processes can mediate injury to the brain when activation is aberrant and prolonged. ROS signaling has been demonstrated to result in damage to cell components; at the same time, ROS production is essential for host defenses (Zhang et al., 2012) .
In this study, we investigated the link between mitochondrial architecture and metabolic reprogramming in primary microglia after induction to a prototypical pro-inflammatory activation state via LPSmediated TLR4 activation. We also used the putative mitochondrial fission inhibitor, Mdivi-1 (Cassidy-Stone et al., 2008) to modulate mitochondrial dynamics in vitro and in vivo. We found that pro-inflammatory activation of microglia changes the mitochondrial dynamics including a metabolic switch from OXPHOS to glycolysis and that Mdivi-1 reverses these effects and the expected LPS-induced cytokine production and ROS production in vitro. Furthermore, we investigated the effect of Mdivi-1 in an in vivo paradigm of neuroinflammation and found that Mdivi-1 reduced the expression of genes related to cytotoxic, repair, and immunomodulatory microglia phenotypes.
| MATERIALS AND METHODS

| Animals of in vitro experiments
Pregnant C57BL/6 mice were sourced from Charles River Laboratories International (Sulzfeld, Germany). C57BL/6J-Tg(CAG-Cox8/EGFP)49Rin mice (Cox8/EGFP; RBRC02250) expressing endogenous green fluorescent protein (GFP) in cytochrome c oxidase, subunit VIIIa of mitochondria (Shitara et al., 2001) were obtained from Riken bio resource center, Japan. Animals were housed and bred at the Experimental Biomedicine animal facility (University of Gothenburg, Gothenburg, Sweden) under specific pathogen free conditions on a 12 hr light/dark 7 cycle with ad libitum access to standard laboratory chow (B&K, Solna, Sweden) and water. All experiments were approved by the local ethical committee at University of Gothenburg (No: 203-2014 and 32-2016) and performed according to the Guidelines for the care and use of Laboratory Animals.
| Microglial cell culture
Primary cultures of purified microglia were created from 1 to 3-dayold C57BL/6 or Cox8/EGFP mice of both sexes, as previously described (Dean et al., 2010) with minor adaptations. Following decapitation, the brain was isolated with the meninges removed and washed in ice-cold Hanks buffered salt solution (HBSS; Sigma-Aldrich, St Louis, MO) supplemented with 100 U/mL penicillin and 100 μg/mL streptomycin (Sigma-Aldrich). Forebrains were dissociated by gentle trituration in Dulbecco's modified Eagle's medium (DMEM; SigmaAldrich) supplemented with 20% heat-inactivated fetal bovine serum (FBS; Fischer Scientific, Goteborg, Sweden) and antibiotics. The cell suspension was passed through a 70-μm cell sieve (Falcon, Corning), plated in 75-cm 2 flasks with vented caps (Sarstedt, Germany) at a density of two brains/flask and cultured undisturbed for 7 days with HBSS/20% FBS/antibiotics. Medium was then replaced with HBSS/10% FBS/antibiotics, and cells were cultured for a further 7 days. Microglia were selectively detached from the flasks by shaking (3 hr, 37 C, 250 rpm) on a rotary shaker, and the microglia cell suspension was collected and centrifuged (250g × 10 min). 
| Live cell imaging
Primary microglia cells were seeded on MatTek (MatTek, Ashland, MA) glass bottom culture dishes. Following cell adherence, cells were exposed to DMSO alone (control) or LPS 100 ng/mL for 24 hr or cells were pretreated with Mdivi-1 (25 μM; Sigma, St. Louis, MO) for 1 hr followed by LPS (100 ng/mL) exposure for 24 hr. Cells were washed gently three times with warm PBS. Furthermore, anti-bleaching live cell visualization medium (DMEMgfp-2, Evrogen) was added to the cells 30 min before imaging. Images were acquired with a Zeiss LSM 880 Airyscan super-resolution system with live cell capabilities and fitted with a fast-ASmodule (Carl Zeiss, Oberkochen, Germany).
Microscopes were equipped with an environmental chamber that maintained 37 C with humidified 5% CO 2 gas during imaging.
| Super-resolution structured illumination microscopy
Super-resolution structured illumination microscopy (SR-SIM) on a Zeiss ELYRA PS.1 microscope (Carl Zeiss Microscopy, Germany) was used to yield a twofold improvement in all spatial directions (Huang, Bates, & Zhuang, 2009 ) beyond the classical Abbe-Rayleigh limit. GFP was imaged using a Plan-Apochromat 100×/1.4 oil objective, an excitation wavelength of 488 nm, and an emission wavelength range of 495-575 nm. The SR-SIM images were acquired as z-stacks with three angles and five phases in each plane and the z-step between planes was 3.30 nm. SR-SIM processing was performed using the Zeiss Zen software package. 3D rendering was done using Volocity 6 (Perkin-Elmer), and figures were compiled using Photoshop CC software (Adobe Systems, San Jose, CA).
| Mitochondrial morphology analysis
Primary microglia were treated with LPS, Mdivi-1, or DMSO as described previously, and mitochondria were categorized based on length: fragmented (<1 μm), tubular (1-3 μm), and elongated (>3 μm), as described previously (Jahani-Asl et al., 2011 consisted of 3 min mixing, 2 min incubation, and 3 min measurement.
All experiments were run in three replicates with 3-4 samples per replicate. Cell counts were used to normalize OCR and ECAR. were rapidly homogenized on ice in 100 μL of ice-cold succinate assay buffer and centrifuged at 10,000g for 5 min to remove insoluble material. Then, cell homogenates were added into a 96-well plate in duplicate wells and mixed with reaction mix provided in with the kit, which results in a colorimetric product proportional to the succinate present. The resultant mixtures were further incubated at 37 C for 20 min. The succinate concentration was determined by the standard curve using spectroscopy at 450 nm wavelength.
| Multiplex cytokine assay
| Measurement of mitochondrial ROS production by live cell imaging
Mitochondrial superoxide generation was assessed in live cells using ) was added to the cells 30 min before imaging. Airyscan super-resolution microscopy on a LSM 880 (Carl Zeiss Microscopy, Germany) with an onboard incubator at 37 C was used to acquire images using a 63× oil objective, an excitation wavelength of 488 nm. Airyscan-processing was done using the Zeiss Zen software package. MitoSox fluorescence was quantified using Volocity 6. 2.12 | Effect of Midivi-1 in an in vivo model of inflammation-mediated damage to the preterm brain
|
We used a well-characterized paradigm of systemic inflammation driven neuroinflammation (Favrais et al., 2011; Krishnan et al., 2017; Van Steenwinckel et al., 2018) , which is known to have effects on brain development and behavior consistent with those reported in infants and children born preterm (Ball et al., 2017; Raju, Buist, Blaisdell, Moxey-Mims, & Saigal, 2017) . Experimental protocols were approved by the institutional guidelines of the Institute National de la Santé et de la Recherche Scientifique (Inserm) France. The treatments was carried out as per previously described in full (Favrais et al., 2011) , with a shortened protocol described below.
Assessments of gene expression were made only in male animals as female animals are not injured in this paradigm, mimicking the male predisposition to injury observed in male preterm born infants (Peacock, Marston, Marlow, Calvert, & Greenough, 2012) . Briefly, mice received twice a day from P1 to P2 and once on P3 a 5-μL intra-peritoneal (IP) injection of 10 μg/kg/injection recombinant mouse IL-1β in phosphate buffered saline (PBS; R&D Systems, Minneapolis, MN), or PBS alone or P1-P3 pups were co-injected with IL-1β and 3 mg/kg/injection of Mdivi-1 (IP, 5 μL).
| Isolation and ex vivo microglia and gene expression analysis
At P3, brains were collected for cell dissociation and CD11B+ cell separation using a magnetic coupled antibody anti-CD11B (Miltenyi, MACS Technology) as previously described in detail (Krishnan et al., 2017; Schang et al., 2014; Shiow et al., 2017) . Microglia are the predominant CD11B cell in this model of injury by more than 100-fold compared with populations of either macrophage or neurtrophil (Krishnan et al., 2017) . Total RNA was extracted from the CD11B+ microglia cells with the RNeasy mini kit (Qiagen, France). RNA quality and concentration were assessed by spectrophotometry (Nanodrop™, Thermofisher Scientific, MA). Reverse transcription was achieved with the iScript™ cDNA synthesis kit (Bio-Rad, France), and RT-qPCR was performed in triplicate for each sample using SYBR Green Super-mix (Bio-Rad) as previously described (Chhor et al., 2013) . Primers were designed using Primer3 plus software (see sequences in Supporting
Information Table S1 ). Specific mRNA levels were calculated after normalization to Rpl13a mRNA (reference gene) based on previous reference gene suitability testing. The data are presented as relative mRNA units with respect to the control group (expressed as fold over control value).
| Statistics
All statistics are reported as mean ± SEM, performed using GraphPad Prism 7.0 (GraphPad Software). Significance scores are * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** p < 0.0001.
3 | RESULTS
| LPS exposure induces excessive mitochondrial fragmentation in microglial cells
Mitochondrial morphology was examined in primary microglia cells cultured from Cox8-EGFP mice exposed to 50 or 100 ng/mL LPS using 3D SR-SIM microscopy. The number of fragmented mitochondria was significantly increased in microglia cells stimulated with 100 ng/mL LPS for 24 hr (Figure 1c) , and elongated and tubular mitochondria were decreased compared with untreated controls (Figure 1g ). These findings are in line with previous studies in BV2 cells (Park et al., 2013) and primary microglia but with a higher dose of LPS (1 μg/mL) (Katoh et al., 2017) . There was no change in the morphology of cells stimulated with 50 ng/mL LPS for 24 hr (Figure 1b,g ).
3.2 | LPS induces a switch from oxidative phosphorylation (OXPHOS) to glycolysis (metabolic reprogramming) in microglia cells 
| Mdivi-1 treatment normalized OCR and ECAR in the microglia cells
Because Mdivi-1 restored mitochondrial morphology, we interrogated its effect on cellular respiration and ECAR-dependent glycolysis and glycolytic capacity (Figure 4a,b,h,i) . Mdivi-1 pretreatment in cells exposed to LPS (100 ng/mL for 6 hr) exhibited a decrease in the level FIGURE 2 LPS dependent metabolic shift. Low dose of LPS (50 ng/mL) induces an increase in mitochondrial respiration and glycolysis: 50 ng/mL LPS treatment shows an increase in basal OCR, ATP-linked OCR (d, e), whereas FCCP-linked maximal OCR (f ) and spare respiratory capacity (g) decreased from 3 to 24 hr. Leak-driven OCR was also increased from 6 to 24 hr. Glycolytic parameters, based on ECAR, tended to increase from 3 to 24 hr (i-n). Whereas a high dose (100 ng/mL) of LPS induces a time-dependent metabolic shift. 100 ng/mL LPS treatment for 6 hr shows an increase in basal OCR, ATP-linked OCR, whereas LPS treatment for 24 hr resulted in a decrease of basal and ATP-linked OCR (r, s). FCCP-linked maximal OCR (t) and spare respiratory capacity (u) decreased from 6 to 24 hr. Leak-driven OCR was increased at 6 hr (v). OCR and ECAR measured for 3, 6, and 24 hr are expressed in bar graph format as the mean ± SEM n = 9. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; Student's t-test calculating the difference between control and LPS treated groups. LPS = lipopolysaccharide; OCR = oxygen consumption rate; FCCP = carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone; ECAR = extracellular acidification rate [Color figure can be viewed at wileyonlinelibrary.com] of basal respiration and ATP-linked OCR to control levels compared with LPS treated cells (Figure 4c,d) . Conversely, Mdivi-1 treatment in cells exposed to 100 ng LPS for 24 hr led to an increase in basal and ATP-linked OCR compared with non-treated LPS exposed cells (Figure 4c,d ). Mdivi-1 treatment also increased FCCP-induced maximal OCR at 24 hr and leak-driven OCR compared with LPS exposed cells at both time points (Figure 4e,f ) . Administration of Mdivi-1 in combination with LPS normalized the spare respiratory capacity (Figure 4g ).
ECAR measurements showed that glycolysis and glycolytic capacity was significantly reduced to control levels in Mdivi-1 treated cells at 6 and 24 hr 100 ng/mL LPS exposure (Figure 4h -k) compared with LPS exposed cells.
| Mdivi-1 reduces the LPS induced release of cytokines and chemokines
To show how LPS activation was inducing an inflammatory reaction in the primary microglia and to test whether this was effected by Mdivi-1, we measured cytokine and chemokine response in microglia conditioned media after treatment with of LPS and or Mdivi-1 (Supporting Information Figures S1 and S2 ). As expected both doses of LPS led to a significant upregulation of essentially all cytokines and chemokines compared with controls. In general, there was much higher cytokine production in microglia exposed to 100 ng-24 hr LPS conditioned media compared with 50 ng-24 hr LPS. We next determined if blockage of mitochondrial fission also modulated LPS-induced expression of cytokine and chemokine mediators. Mdivi-1 significantly reduced the pro-inflammatory cytokines (IL-1α, IL-6, TNF-α, IL-12(p40)), chemokines (G-CSF, CCL5, RANTES), and anti-inflammatory cytokines (IL-10, IL-13) and the chemokines (monocyte chemotactic protein 1 (MCP-1 β), in response to 100 ng/mL of LPS for 24 hr. The LPSinduced production of IL-2, IL-5, and MIP1 α were not significantly reduced by Mdivi-1 ( Figure 5 ).
| Mdivi-1 suppresses LPS-induced succinate production
Succinate is a well-established pro-inflammatory metabolite that is known to accumulate during LPS-induced macrophage activation (Mills et al., 2016) , but the role of succinate during microglia activation needs further investigation. We found that LPS (100 ng/mL) resulted in a significant increase of succinate (Figure 6a ) accompanying the expression of pro/anti-inflammatory cytokines and chemokines.
Mdivi-1 pretreatment (Figure 6a ) or blocking succinate production by succinate dehydrogenase inhibitor (DMM, 10 mM) (Figure 6b ) normalized succinate production. These results were further strengthened by Figure S3 ). Excessive fission results in fragmented mitochondria and causes a metabolic shift in microglia (Khacho et al., 2014 ) from OCR to ECAR. This may result in increased succinate production which in turn acts as a feedback loop to amplify aberrant mitochondrial fission (Lu et al., 2018) .
3.7 | Inhibition of mitochondria fission by Mdivi-1 suppresses mitochondrial ROS production rectly show that that mitochondrial fission (induced by TLR4 stimulation) increases ROS production as shown in this study and others (Katoh et al., 2017; Park et al., 2013) .
| Mdivi-1 treatment attenuated LPS induced increase of mitochondrial membrane potential
Our data suggest that after LPS (100 ng/mL) exposure for 24 hr microglia mainly depended on glycolysis for energy production. Therefore, we investigated the mitochondrial membrane potential using the mitochondrial membrane potential probe JC-1 in these conditions.
We found that there was a consequent elevation of mitochondrial FIGURE 4 Mdivi-1 treatment reversed the metabolic shift. Inhibition of DRP1 by Mdivi-1 resulted in reduced basal OCR and ATP-linked OCR at 6 hr, whereas Mdivi-1 increased basal OCR and ATP-linked OCR at 24 hr compared with 100 ng/mL LPS exposure (c, d). LPS induced reduction in FCCP-induced maximal respiration and leak-driven OCR at 24 hr, which was normalized by Mdivi-1 (e, f ). The LPS-evoked drop in SRC was prevented by Mdivi-1 (g). Mdivi-1 normalized LPS-induced increased ECAR dependent glycolysis and glycolytic capacity (j, h). OCR and ECAR measured for 3, 6, and 24 hr are expressed in bar graph format as the mean ± SEM, n = 6-9. ***p ≤ 0. 3.9 | Mdivi-1 treatment attenuated microglial activation in a mouse paradigm of neuroinflammation Based on our working hypothesis that Mdivi-1 can reduce the inflammatory reaction of microglia, we sought to investigate the potential for Mdivi-1 to reduce the activation of microglia in vivo (Favrais et al., 2011; Krishnan et al., 2017) . We isolated microglia from the brains of animals at P3 following induction of systemically driven neuroinflammation and con-current treatment with Mdivi-1 from P1 to P3. We analyzed the isolated microglia for gene expression of markers associated with functional phenotypes including cytotoxic (Nos2, Ptgs2, Cd32), repair and regeneration (Arg1, Lga3, Igf1), and immunomodulatory (Il1ra, Il4a, Socs3) phenotypes. Exposure to neuroinflammatorystimuli affected the gene expression as expected (Krishnan et al., 2017) , with increased expression of all of the genes except for the gene for IGF1, which was decreased. IGF1 is a pleotropic growth factor necessary for myelonogenesis and known to be decreased by proinflammatory microglial activation (Wlodarczyk et al., 2017) . Mdivi-1
Mdivi-1 treatment abolished lipopolysaccharide (LPS) induced exaggerated pro/anti-inflammatory cytokine and chemokine response. Microglia cells were pretreated with Mdivi-1 (25 μM) for 1 hr followed by LPS (100 ng/mL) for 24 hr, and microglial cells were collected and analyzed by 23-plex cytokine assay. Heat maps show cytokine concentration (pg/mL). KC = keratinocyte chemoattractant. n = 8 *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; Student's t-test calculating the difference between LPS and LPS + Mdivi-1 treated groups [Color figure can be viewed at wileyonlinelibrary.com] treatment normalized to control (PBS) levels the expression of genes associated with cytotoxicity and immunomodulation, but had no effect on IGF1 gene expression, and only partly recovered Galectin-3 gene expression (Lgal3), indicating that exposure to Mdivi-1, which inhibits mitochondrial fragmentation, modulates the microglial inflammatory response also in vivo (Figure 9 ).
| DISCUSSION
This study strengthens our knowledge of the links between mitochondrial architecture, inflammation, and energy metabolism in microglial cells. We have shown that activation of microglia to a proinflammatory activation state increased mitochondrial fragmentation, which was accompanied by a reduction in oxidative phosphorylation and an increase in glycolysis, which was dose and time dependent.
Pretreatment with the putative mitochondrial division inhibitor, Mdivi-1, normalized LPS-induced mitochondrial fragmentation, normalized the cellular respiration and glycolysis to control levels.
Mdivi-1 greatly reduced LPS-induced cytokine production normalized LPS-induced ROS production and mitochondrial membrane potential.
Neuroinflammation includes complex changes in microglial phenotypes, mediated by gene expression changes leading to the production of cytokines and chemokines and production of ROS. Altogether this triggers oxidative and nitrosative stress in the brain (Bolouri et al., 2014; Hellström Erkenstam et al., 2016) . We observed as expected that LPS-activated microglia produced a plethora of chemokines and cytokines and ROS. In this pro-inflammatory scenario, suppression of LPS-induced mitochondrial ROS plays a role in modulating the production of pro-inflammatory mediators by preventing MAPK and NF-κB activation suggesting a potential therapy for inflammationassociated degenerative neurological diseases (Park et al., 2015) . To understand LPS-induced changes in mitochondrial structure, we used high-resolution 3D ELYRA-SIM (Shim et al., 2012) to quantify mitochondrial morphology which revealed that high-dose LPS for 24 hr increased fragmentation. A low dose of LPS caused an initial increase in OCR which was not accompanied by any change in mitochondrial morphology. However, a higher dose of LPS induced a decrease of OCR and a further increase of ECAR accompanied by mitochondrial fission. Fragmented mitochondria constitute the preferred morphological state when respiratory activity is low (Westermann, 2012) . A high or moderate dose of LPS caused a decrease in respiration, and cells became dependent on glycolysis favoring excessive fragmentation. The molecular mechanisms behind this response is not known, but it has been proposed that the energy depletion elicits mitochondrial fragmentation and subsequent mitophagy (Youle & van der Bliek, 2012) . Increased mitochondrial fragmentation due to excessive fission can exacerbate the inflammatory response of microglia (Ho et al., 2018) through modulation of DRP1
de-phosphorylation and elimination of ROS . We chose to use Mdivi-1, a mitochondrial division inhibitor, to study microglial metabolism as it related to mitochondrial morphology as previous studies revealed that LPS exposure in microglia cells leads to activation of mitochondrial fission protein DRP1 (Katoh et al., 2017; Park et al., 2013) .
Mdivi-1 is a widely accepted DRP-1 mediated mitochondrial fission inhibitor used in many studies (Baek et al., 2017; Peiris-Pagès, Bonuccelli, Sotgia, & Lisanti, 2018; So, Hsing, Liang, & Wu, 2012; Xie et al., 2013) . Our data supports the assertion that changes in mitochondrial dynamics may be needed for the expression of inflammatory mediators in activated microglia cells. Mdivi-1 has previously been shown to attenuate LPS-induced ROS and pro-inflammatory mediator production in a BV-2 microglial cell line (Park et al., 2013 ) with a very high dose of 1 μg/mL. BV2 cells are similar to primary microglia (Henn et al., 2009) , and Socs3 were assessed by qRT-PCR from MACS isolated CD11b + microglia from P3 mice. Protein names for the genes are shown in brackets on the panels. The legend indicates that the first bar (blue) is the control (PBS injected group), the middle bar (red) is the neuroinflammatory challenge group, and that the right bar (green) is the group challenged with neuroinflammation but also treated with Mdivi-1. The dotted line highlights the gene expression in the control group. Results are expressed as the mean ± SEM. There are 10-15 data points from three independent experiments per group. Data were analyzed with a Kruskal-Wallis ANOVA, p < 0.001 with a Dunn's test for comparison among groups: **p < 0.01, ***p < 0.001, ****p < 0.0001 [Color figure can be viewed at wileyonlinelibrary.com] mitochondrial fragmentation and expression of pro-inflammatory mediators but also normalized mitochondrial function in microglia.
These data support the suggestion that increasing the fusion/fission ratio reduces the extent of neuroinflammation (Kim, Lee, Park, Kim, & Roh, 2016) . To further support the potential validity of targeting fission as a therapeutic strategy, we tested the ability of Mdivi-1 to modify microglial activity in vivo. We used a paradigm of systemically driven neuroinflammation, wherein an IP injection of the inflammatory agent interleukin-1β induces a highly complex neuroinflammatory reaction involving microglia (Krishnan et al., 2017; Van Steenwinckel et al., 2018) . Supporting our in vitro data mdivi-1 was able to reduce the expression of genes associated with classically pro-inflammatory genes and the anti-inflammatory activation state, which is associated with the in vivo inflammatory reaction.
Previous work with BV2 demonstrated that LPS causes an inhibition of OXPHOS (Voloboueva, Emery, Sun, & Giffard, 2013) . However, this study used a very high dose of LPS (1 μg/mL) which is shown to elicit mitochondrial toxicity (Ahn et al., 2012) . We demonstrate for the first time that a low or moderate dose of LPS (50 ng/mL) results in an increase of ATP-linked OCR and basal respiration in support of another study in skeletal muscle cells where they used a very low dose of LPS in isolated mitochondria (Frisard et al., 2015) . High dose of LPS (100 ng/mL) caused a decrease in FCCP-induced maximal respiration and an increase in leak-driven respiration. A depletion of spare respiratory capacity was found at 6 and 24 hr following LPS exposure. However, we have noted no significant difference in cell viability or death after LPS.
OCR exhibited a biphasic response characterized initially by an increase of OCR in response to low LPS and then a marked drop of OCR after moderate to high doses of LPS, whereas ECAR increased in proportion to the dose of LPS. We interpret the initial increase of OCR as a means to match an increased demand of ATP. However, as the pro-inflammatory stimulus becomes stronger, it appears favorable to shift from mitochondrial respiration to aerobic glycolysis (Warburg effect) to promote more rapid ATP production (Kelly & O'Neill, 2015; Orihuela et al., 2016) and synthesis of inflammatory mediators such as cytokines/chemokines and ROS (Kelly & O'Neill, 2015) . We believe the Warburg effect is an important concept for understanding metabolic changes occurring during microglial activation. It is shown that also activation of macrophages or DCs with LPS induces a metabolic switch from OXPHOS to glycolysis (Krawczyk et al., 2010) . Metabolic shift may be facilitated by increased mitochondrial fission and/or reduced fusion mediated by DRP1 activation (Baker, Maitra, Geng, & Li, 2014) . However, as glycolysis is less efficient at producing ATP than OXPHOS, this metabolic reorientation cannot solely be to meet energy demands. Glycolysis may also facilitate cytokine production by producing intermediate metabolites (Mills et al., 2016) . A previous study found that glycolysis was required to produce optimal IFN-γ during T cell activation and is translationally regulated by the binding of the glycolysis enzyme GAPDH to IFN-γ mRNA (Chang et al., 2013) .
Our results in microglia add to what has already been shown in DCs and macrophages (Williams & O'Neill, 2018) , specifically that proinflammatory activation resulted in increased succinate accumulation.
In DCs and macrophages, this succinate accumulation was related to an altered Krebs cycle and this was normalized by Mdivi-1. Aberrant mitochondrial fission alters the Krebs cycle, by interfering with the processes after citrate and after succinate (Jha et al., 2015) by reducing of cytochrome c oxidase and succinate dehydrogenase activity . Impaired succinate dehydrogenase activity results in succinate accumulation due to impaired succinate to fumarate conversion (Mills et al., 2016) . Accumulated succinate drives reverse electron transport (RET) to generate excessive mitochondrial ROS production (Chouchani et al., 2014; Niatsetskaya et al., 2012) . Our data support this link between accumulation of succinate and ROS production, which was prevented by Mdivi-1.
LPS induced an increase in proton leak with an increase in membrane potential. Proton leak is partly mediated by uncoupling proteins (UCPs) present in the mitochondrial inner membrane (Hass & Barnstable, 2016; Krauss, Zhang, & Lowell, 2005) . It is shown that in primary microglia LPS induces an increase in UCP2 levels and membrane potential. UCP2-silenced microglia stimulated with LPS show a decrease in membrane potential (De Simone et al., 2015) . In macrophages LPS stimulation repurpose their mitochondria from ATP production to succinate-dependent ROS generation, with glycolysis taking on the role of ATP generation. In this case, mitochondria sustain a high membrane potential because protons generated by the electron transport chain to make ATP are no longer being consumed by mitochondrial ATP synthase (Mills et al., 2016) . Macrophages can also reorganize their respiratory chain in response to a bacterial infection, decreasing Complex I levels and increasing the activity of Complex II (Garaude et al., 2016) . These changes boost production of proinflammatory cytokines such as interleukin 1β (IL-1β). Our data support these findings as normalizing mitochondrial membrane potential and ROS production with Mdivi-1 abolished pro-and antiinflammatory cytokine and chemokine release.
Aberrant activation of microglial affects neurodegenerative processes through various neurotoxic cascades. We have shown that pro-inflammatory microglial activation alters cellular bioenergetics by inducing mitochondrial dysfunction and promoting a switch to glycolysis, supported by excessive mitochondrial fragmentation, and increased cytokine output. This is likely an adaptive mechanism as the transition of sensing and surveying microglia into an activated state is likely to be accompanied by significantly increased energy consumption. Preventing excessive mitochondrial fission in microglial cells stimulated with LPS using a fission inhibitor Mdivi-1 normalizes mitochondrial respiration and glycolysis and attenuates the release of cytokines/chemokines. These lines of in vitro morphological and functional data and the in vivo data suggest that regulating mitochondrial dynamics may be a useful therapeutic modality for preventing neurological disorders caused by aberrant microglia activation. In addition, the authors acknowledge financial support from the
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